Percutaneous Ultrasonic Tenotomy Versus Platelet Rich Plasma for Gluteal Tendinopathy

Inclusion Criteria: * Males and Females 18 - 70 years of age (inclusive) * Clinical symptoms for a minimum of three months * Subjects have a baseline pain score of \> 3 * Partial-thickness gluteal tendon tear (gluteus medius or gluteus minimus) defined as \<50% partial-thickness tear of either tendon or imaging abnormalities consistent with tendinosis on a 3 Tesla MRI or diagnostic ultrasound within the last 3 months, as determined by the Investigator Exclusion Criteria: * Age \< 18 or \> 70 * Corticosteroid injection in the index gluteal bursae within the last 3 months * Subjects who have received more than one (1) previous corticosteroid injections or percutaneous tenotomy procedure or any biologic treatment in the index gluteal bursae at any point in the past. * Severe arthrosis of the femoral-acetabular joint * A high-grade gluteal tendon tear (\>50% partial-thickness tear) * Previous hip surgery on the affected side * Previous or current history of labral pathology on the affected side * Lumbar radiculopathy impacting the index hip * History of systemic malignant neoplasms within the last 5 years * Malignant or local neoplasm within the last 6 months or any history of local neoplasm at the site of administration (on the affected side) * Receiving immunosuppressive therapy * Active regimen of chemotherapy or radiation-based treatment * Allergy to sodium citrate or any "caine" type of local anesthetic * Pregnancy * Subject is currently participating in another clinical …